CAPTRUST Financial Advisors
IMUC

CAPTRUST Financial Advisors’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

CAPTRUST Financial Advisors’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3
Closed – – 3671
2020
Q3 		$0 Sell
3
-22
-88% – ﹤0.01% 3416
2020
Q2 		$0 Buy
+25
New – ﹤0.01% 2973

CAPTRUST Financial Advisors's IMUC Position: Q4 2020 in Review

CAPTRUST Financial Advisors sold out of ImmunoCellular Therapeutics, Ltd. (IMUC) in Q4 2020, closing a stake of 3 shares.

CAPTRUST Financial Advisors first reported a position in IMUC in Q2 2020 and held it in 2 quarters. The position peaked at $0 in Q3 2020. 0 funds tracked by Wall St. Rank hold IMUC as of Q4 2020.

  • CAPTRUST Financial Advisors reported no remaining ImmunoCellular Therapeutics, Ltd. position as of Q4 2020 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 3 ImmunoCellular Therapeutics, Ltd. shares in Q4 2020.
  • CAPTRUST Financial Advisors first reported a position in ImmunoCellular Therapeutics, Ltd. in Q2 2020 and held it in 2 quarters.
  • CAPTRUST Financial Advisors's ImmunoCellular Therapeutics, Ltd. position peaked at $0 in Q3 2020.
  • 0 funds tracked by Wall St. Rank held ImmunoCellular Therapeutics, Ltd. as of Q4 2020.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.